Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker ACHV
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Aug 19, 2026 | Richard Alistair Stewart Director | ACHV Achieve Life Sciences, Inc. | Sale | 20,626 | $8.49 | $175.1K Sale | Form 4 ↗ |
| Sep 18, 2025 | Mark K. Oki Chief Financial Officer | ACHV Achieve Life Sciences, Inc. | Sale | 50,060 | $2.92 | $146.2K Sale | Form 4 ↗ |
| Sep 18, 2025 | Richard Alistair Stewart Chief Executive Officer, Director | ACHV Achieve Life Sciences, Inc. | Sale | 129,501 | $2.92 | $378.1K Sale | Form 4 ↗ |
| Sep 4, 2025 | Jerry Wan Principal Accounting Officer | ACHV Achieve Life Sciences, Inc. | Sale | 14,070 | $2.77 | $39.0K Sale | Form 4 ↗ |
| Sep 4, 2025 | Thomas Braxton King Director | ACHV Achieve Life Sciences, Inc. | Sale | 139,858 | $2.77 | $387.4K Sale | Form 4 ↗ |
| Sep 4, 2025 | Cindy Jacobs President & CMO | ACHV Achieve Life Sciences, Inc. | Sale | 27,629 | $2.77 | $76.5K Sale | Form 4 ↗ |
| Sep 4, 2025 | Jaime Xinos Chief Commercial Officer | ACHV Achieve Life Sciences, Inc. | Sale | 20,854 | $2.77 | $57.8K Sale | Form 4 ↗ |
| Mar 17, 2025 | Mark K. Oki Chief Financial Officer | ACHV Achieve Life Sciences, Inc. | Buy | 10,000 | $2.89 | $28.9K Buy | Form 4 ↗ |
| Mar 17, 2025 | Richard Alistair Stewart Chieve Executive Officer, Director | ACHV Achieve Life Sciences, Inc. | Buy | 10,000 | $2.86 | $28.6K Buy | Form 4 ↗ |
9 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:55 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances